HighTower Advisors »

Athira Pharma shares owned by HighTower Advisors

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $30k 13k 2.41
2023-09-30 $26k 13k 2.07
2023-06-30 $37k 13k 2.95

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)

View all positions for HighTower Advisors

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
BML Capital Management
Millennium Management
Pathstone Holdings
Citadel Advisors
Dimensional Fund Advisors
Two Sigma Investments
GSA Capital Partners
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Athira Pharma